The life sciences company Varro has picked St. Louis as where it wants to grow as it looks to develop commercially available medical devices that can rapidly detect pathogens easily spread through the air such as the flu, COVID and…
Tom Cirrito, Ph.D., CEO of Varro Bio, was pleased to speak at Devcon 2024, taking place in Bangkok, Thailand. His presentation, titled Next-Generation Platform to Prevent the Spread of Infectious Disease, can be viewed below: https://www.youtube.com/watch?v=fHaE0iv9Szs About Devcon: Devcon is…
Recall how long it took, in the depths of the COVID-19 pandemic, to screen yourself with the gold-standard method, the PCR test: You’d swab your nostrils, hand the swab to the person at the pharmacy or clinic, then wait while…
Varro Receives $20 Million from Vitalik Buterin to Support Development of Cutting-Edge Pathogen Biosensor Technology Varro to enable improved pathogen detection worldwide by making its proprietary biosensor tech platform available via Open Source NEW YORK, ST. LOUIS and SINGAPORE -…
Technology developed by Washington University in St. Louis that detects SARS-CoV-2 and other viral, bacterial, and fungal pathogens in people and spaces in under 60 seconds Addressing new threats: In the event a new pathogenic threat emerges, Varro can create…
Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a…
The scientific journal ACS Sensors published a report by Varro Life Science’s academic collaborators entitled “Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care.” The research notes that “Our platform holds the potential to be adapted for…